Donghoon Lee has been appointed as the President and CEO of SK Biopharmaceuticals.
3 reports, 3 independent
Updated Jul 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Donghoon Lee has been appointed as the President and CEO of SK Biopharmaceuticals.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Donghoon Lee assumes the role of President and CEO at SK Biopharmaceuticals.1 source
SK Biopharmaceuticals and Insilico announced a new R&D collaboration.1 source
Keep exploring
The entities involved
-
Insilico Medicine
American biotechnology company
Nothing else this week.
-
Donghoon Lee
researcher ORCID ID = 0000-0001-5220-3991
Nothing else this week.